Sign in to view content

Cost of Initial Aflibercept, Laser, or Observation in Eyes With Diabetic Macular Edema and Good Vision Based on Management Approaches in Protocol V

Jennifer K. Sun, MD

Video
Published 2020

Related

Biosimilar Paradox: How Biosimilar Use Will Increase Patient and Healthcare Costs
Ravi Parikh, MD MPH
Annual Meeting Talks
2023
Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2018
Aflibercept 8 mg for Diabetic Macular Edema: 2-Year Results of the Phase 2/3 PHOTON Trial
Diana V Do, MD, FASRS
Annual Meeting Talks
2023

Category: Socioeconomics

See more